Drug Search Results
More Filters [+]

ED-001

Alternative Names: ED-001, ED001
Latest Update: 2023-07-19
Latest Update Note: Clinical Trial Update

Product Description

ED001 is a digital therapeutic for postpartum depression. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05551195?term=ed001&draw=2&rank=1)

Mechanisms of Action: Device

Novel Mechanism: No

Modality: Device

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Woebot Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ED-001

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

WB001-001

N/A

Terminated

Depression, Postpartum

2023-05-10

Recent News Events